Literature DB >> 32010362

HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.

D Grigorie1,2, A Sucaliuc1, S Ciuffi3, F Franceschelli3, F Marini3, D Ioachim4, D Terzea4, M L L Brandi3.   

Abstract

CONTEXT: Hyperparathyroidism-jaw tumour (HPT-JT) syndrome is a rare autosomal dominant cause of familial hyperparathyroidism associated with ossifying fibromas (OF) of the maxillofacial bones and increased risk of parathyroid carcinoma, caused by inactivating germline mutation of the cell division cycle 73 (CDC73) gene.
OBJECTIVE: To report the first Romanian family with HPT-JT and genetic screening of CDC73 gene. SUBJECTS AND METHODS: Mutational analysis of the CDC73 gene and genetic screening of the family of a proband with HPT-JT. Histological diagnosis of parathyroid tumors (WHO criteria) and immunohistochemistry (parafibromin) were performed.
RESULTS: Three of the six screened family members had evidence of PHPT and surgically proven parathyroid tumours. Two of the three affected members had parathyroid carcinomas and one had two parathyroid adenomas. Genetic screening of CDC73 gene revealed that 4 of 6 patients showed a heterozygous germline deletion of one nucleotide: c.128-IVS1+1 delG. All the three affected patients, resulted to be carriers of the CDC73 mutation, but each one bearing a different CDC73 polymorphism.
CONCLUSIONS: We identified a new CDC73 germline mutation in a Romanian family of HPT-JT. Analysis of clinical phenotypes in the four mutated individuals confirmed the incomplete penetrance and the variable clinical expression of the disease. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Familial Primary Hyperparathyroidism; Genetic screening; Germline CDC73 mutation; HPT-JT; Parathyroid Carcinoma

Year:  2019        PMID: 32010362      PMCID: PMC6992406          DOI: 10.4183/aeb.2019.398

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  16 in total

Review 1.  Heritable forms of primary hyperparathyroidism: a current perspective.

Authors:  Ronald A DeLellis; Shamlal Mangray
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

2.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Authors:  J D Carpten; C M Robbins; A Villablanca; L Forsberg; S Presciuttini; J Bailey-Wilson; W F Simonds; E M Gillanders; A M Kennedy; J D Chen; S K Agarwal; R Sood; M P Jones; T Y Moses; C Haven; D Petillo; P D Leotlela; B Harding; D Cameron; A A Pannett; A Höög; H Heath; L A James-Newton; B Robinson; R J Zarbo; B M Cavaco; W Wassif; N D Perrier; I B Rosen; U Kristoffersson; P D Turnpenny; L-O Farnebo; G M Besser; C E Jackson; H Morreau; J M Trent; R V Thakker; S J Marx; B T Teh; C Larsson; M R Hobbs
Journal:  Nat Genet       Date:  2002-11-18       Impact factor: 38.330

3.  CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.

Authors:  Karin van der Tuin; Carli M J Tops; Muriel A Adank; Jan-Maarten Cobben; Neveen A T Hamdy; Marjolijn C Jongmans; Fred H Menko; Bernadette P M van Nesselrooij; Romana T Netea-Maier; Jan C Oosterwijk; Gerlof D Valk; Bruce H R Wolffenbuttel; Frederik J Hes; Hans Morreau
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 4.  Endocrine neoplasms in familial syndromes of hyperparathyroidism.

Authors:  Yulong Li; William F Simonds
Journal:  Endocr Relat Cancer       Date:  2016-05-20       Impact factor: 5.678

5.  Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.

Authors:  Maurizio Iacobone; Giulia Masi; Luisa Barzon; Andrea Porzionato; Veronica Macchi; Francesco Antonio Ciarleglio; Giorgio Palù; Raffaele De Caro; Giovanni Viel; Gennaro Favia
Journal:  Langenbecks Arch Surg       Date:  2009-06-16       Impact factor: 3.445

6.  Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.

Authors:  Luqman Sulaiman; Felix Haglund; Jamileh Hashemi; Takao Obara; Jörgen Nordenström; Catharina Larsson; C Christofer Juhlin
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.

Authors:  Anthony J Gill; Grace Lim; Veronica K Y Cheung; Juliana Andrici; Joanna L Perry-Keene; Julie Paik; Loretta Sioson; Adele Clarkson; Amy Sheen; Catherine Luxford; Marianne S Elston; Goswin Y Meyer-Rochow; M Teresa Nano; Schelto Kruijff; Anton F Engelsman; Mark Sywak; Stanley B Sidhu; Leigh W Delbridge; Bruce G Robinson; Deborah J Marsh; Christopher W Toon; Angela Chou; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2019-01       Impact factor: 6.394

8.  Fine-needle aspiration cytology of parathyroid carcinoma mimic hürthle cell thyroid neoplasm.

Authors:  Chutintorn Sriphrapradang; Pattana Sornmayura; Niramol Chanplakorn; Objoon Trachoo; Pattarana Sae-Chew; Rangsima Aroonroch
Journal:  Case Rep Endocrinol       Date:  2014-08-10

9.  Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome.

Authors:  Marco Mele; Lars Rolighed; MarieLouise Jespersen; Lars Rejnmark; Peer Christiansen
Journal:  Int J Endocrinol Metab       Date:  2016-04-23

Review 10.  Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.

Authors:  Luís Cardoso; Mark Stevenson; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2017-09-25       Impact factor: 4.878

View more
  2 in total

1.  GIANT MEDIASTINAL PARATHYROID ADENOMAS AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 1: A DIAGNOSTIC CONUNDRUM.

Authors:  A Gautam; A Rastogi; S K Bhadada
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

2.  Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.

Authors:  Angela Toss; Paola Quarello; Fedro Alessandro Peccatori; Andrea Ferrari; Maurizio Mascarin; Giuseppe Luigi Banna; Marco Zecca; Saverio Cinieri
Journal:  Curr Oncol Rep       Date:  2022-03-23       Impact factor: 5.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.